| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00432-008-0431-1 |
| P698 | PubMed publication ID | 18618142 |
| P50 | author | Mitsune Tanimoto | Q71779893 |
| Katsuyuki Kiura | Q71792097 | ||
| Katsuyuki Hotta | Q91655587 | ||
| Nagio Takigawa | Q97688488 | ||
| Hiroshi Ueoka | Q114418730 | ||
| Yoshiro Fujiwara | Q114418733 | ||
| Kenichi Gemba | Q114418736 | ||
| Toshiro Yonei | Q114418737 | ||
| Tomonori Moritaka | Q114418739 | ||
| Takuo Shibayama | Q114418740 | ||
| Yoshihiko Segawa | Q114418746 | ||
| Haruhito Kamei | Q114418748 | ||
| Keisuke Aoe | Q114418763 | ||
| Shoichi Kuyama | Q114418774 | ||
| Masahiro Tabata | Q124969393 | ||
| P2093 | author name string | Keisuke Sugimoto | |
| Keisuke Matsuo | |||
| Akihiko Bessho | |||
| P2860 | cites work | Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 |
| Cancer statistics, 2007 | Q29547293 | ||
| Reporting results of cancer treatment | Q29620070 | ||
| Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) | Q29620605 | ||
| Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer | Q33362244 | ||
| Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. | Q34533636 | ||
| Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. | Q34546316 | ||
| The TP53 gene, tobacco exposure, and lung cancer | Q35078733 | ||
| Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smoking | Q35551048 | ||
| Trends in cigarette smoking in the United States. The epidemiology of tobacco use | Q35920774 | ||
| Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology | Q36123334 | ||
| Treatment of non-small-cell lung cancer and pharmacogenomics: where we are and where we are going | Q36388906 | ||
| Implications and prognostic value of K-ras mutation for early-stage lung cancer in women | Q38466609 | ||
| Cigarette smoking and changes in the histopathology of lung cancer | Q38503712 | ||
| Long-standing debate on cisplatin- versus carboplatin-based chemotherapy in the treatment of advanced non-small cell lung cancer | Q43578608 | ||
| A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer | Q43922523 | ||
| Clinical significance of epidermal growth factor receptor gene mutations on treatment outcome after first-line cytotoxic chemotherapy in Japanese patients with non-small cell lung cancer | Q44097671 | ||
| Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer | Q45098702 | ||
| Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer | Q46591327 | ||
| Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience | Q46755113 | ||
| p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. | Q50995831 | ||
| Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. | Q51023039 | ||
| Women's susceptibility to tobacco carcinogens. | Q53635229 | ||
| Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese | Q57918768 | ||
| Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials | Q57918953 | ||
| Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group | Q71791969 | ||
| Re: Endocrine factors and adenocarcinoma of the lung in women | Q72418933 | ||
| P433 | issue | 1 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| adenocarcinoma of the lung | Q843799 | ||
| P304 | page(s) | 117-123 | |
| P577 | publication date | 2008-07-11 | |
| P1433 | published in | Journal of Cancer Research and Clinical Oncology | Q2081599 |
| P1476 | title | Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group experience | |
| P478 | volume | 135 |
Search more.